this piece corresponds to the legacy myPDB login in the form of a bootstrap modal, will likely retire-->

Chemical Component Summary

NameL-EPINEPHRINE
Identifiers4-[(1R)-2-(methylamino)-1-oxidanyl-ethyl]benzene-1,2-diol
FormulaC9 H13 N O3
Molecular Weight183.20 g/mol
Typenon-polymer
Isomeric SMILESCNC[C@H](O)c1ccc(O)c(O)c1
InChIInChI=1S/C9H13NO3/c1-10-5-9(13)6-2-3-7(11)8(12)4-6/h2-4,9-13H,5H2,1H3/t9-/m0/s1
InChIKeyUCTWMZQNUQWSLP-VIFPVBQESA-N

Chemical Details

Formal Charge0
Atom Count26
Chiral Atom Count1
Chiral AtomsC7
Bond Count26
Aromatic Bond Count6
Leaving Atomsn/a

Drug Info: DrugBank

DrugBank IDDB00668 Different stereochemistry
NameEpinephrine
Groups
  • approved
  • vet_approved
DescriptionThe active sympathomimetic hormone from the adrenal medulla in most species. It stimulates both the alpha- and beta- adrenergic systems, causes systemic vasoconstriction and gastrointestinal relaxation, stimulates the heart, and dilates bronchi and cerebral vessels. It is used in asthma and cardiac failure and to delay absorption of local anesthetics. [PubChem]
Synonyms
  • (-)-(R)-Epinephrine
  • (-)-3,4-Dihydroxy-alpha-((methylamino)methyl)benzyl alcohol
  • (-)-Adrenaline
  • (−)-adrenaline
  • (R)-(-)-Adnephrine
Salts
  • Epinephrine acetate
  • Epinephrine bitartrate
  • Epinephrine chloride
  • Epinephrine hydrochloride
Brand Names
  • 2% Lidocaine and Epinephrine 1:100,000 Injection USP
  • 4% Astracaine Dental With Epinephrine 1:200,000
Affected OrganismHumans and other mammals
IndicationUsed to treat anaphylaxis and sepsis. Also one of the body's main adrenergic neurotransmitters.
PharmacologyEpinephrine is indicated for intravenous injection in treatment of acute hypersensitivity, treatment of acute asthmatic attacks to relieve bronchospasm, and treatment and prophylaxis of cardiac arrest and attacks of transitory atrioventricular heart block with syncopal seizures (Stokes-Adams Syndrome). The actions of epinephrine resemble the effects of stimulation of adrenergic nerves. To a variable degree it acts on both alpha and beta receptor sites of sympathetic effector cells. Its most prominent actions are on the beta receptors of the heart, vascular and other smooth muscle. When given by rapid intravenous injection, it produces a rapid rise in blood pressure, mainly systolic, by (1) direct stimulation of cardiac muscle which increases the strength of ventricular contraction, (2) increasing the heart rate and (3) constriction of the arterioles in the skin, mucosa and splanchnic areas of the circulation. When given by slow intravenous injection, epinephrine usually produces only a moderate rise in systolic and a fall in diastolic pressure. Although some increase in pulse pressure occurs, there is usually no great elevation in mean blood pressure. Accordingly, the compensatory reflex mechanisms that come into play with a pronounced increase in blood pressure do not antagonize the direct cardiac actions of epinephrine as much as with catecholamines that have a predominant action on alpha receptors.
Mechanism of actionEpinephrine works via the stimulation of alpha and beta-1 adrenergic receptors, and a moderate activity at beta-2 adrenergic receptors.
Route of administration
  • Dental
  • Dental; Infiltration
  • Dental; Subcutaneous
  • Endotracheal; Intracardiac; Intramuscular; Intravenous; Subcutaneous
  • Endotracheal; Intracardiac; Intravenous
Categories
  • Adrenergic Agents
  • Adrenergic Agonists
  • Adrenergic alpha-Agonists
  • Adrenergic beta-Agonists
  • Alcohols
ATC-Code
  • R03AK01
  • R01AA14
  • S01EA51
  • C01CA24
  • R03AA01
AHFS-Code
  • 12:12.12
  • 52:24.00
  • 52:32.00
  • 92:02.00*
CAS number51-43-4

Drug Targets

NameSequence SearchPharmacological ActionActions
Alpha-1D adrenergic receptorMTFRDLLSVSFEGPRPDSSAGGSSAGGGGGSAGGAAPSEGPAVGGVPGGA...unknownantagonist
Alpha-1D adrenergic receptorMTFRDLLSVSFEGPRPDSSAGGSSAGGGGGSAGGAAPSEGPAVGGVPGGA...unknownantagonist
Alpha-1D adrenergic receptorMTFRDLLSVSFEGPRPDSSAGGSSAGGGGGSAGGAAPSEGPAVGGVPGGA...unknownantagonist
Alpha-1B adrenergic receptorMNPDLDTGHNTSAPAHWGELKNANFTGPNQTSSNSTLPQLDITRAISVGL...yesagonist
Alpha-1B adrenergic receptorMNPDLDTGHNTSAPAHWGELKNANFTGPNQTSSNSTLPQLDITRAISVGL...yesagonist
View More
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS. Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682